Alvotech is listed on Nasdaq for a public offering, targeting investors in the European Economic Area.
1 report, 1 independent
Updated Jun 16
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Alvotech is listed on Nasdaq for a public offering, targeting investors in the European Economic Area.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Alvotech
biotechnology company
Nothing else this week.
-
Nasdaq
American fully electronic stock exchange
Related events
- Alvotech utilized Nasdaq for its public stock listing and is currently undergoing comprehensive review by the FDA for biosimilar applications.
- Alarum Technologies is listed on the Nasdaq stock exchange.
- Snowflake Inc. listed its shares on the Nasdaq stock exchange on September 25, 2026.
- TurboGen Ltd. announced plans for commercialization in the US and EU, alongside its listing on Nasdaq.
- InnovAge listed its shares on the electronic stock exchange on September 8, 2026.